![5,10-Dihydro-2-methyl-4H-thieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Impurity)](https://static.cymitquimica.com/products/TR/img/D449185.png "Click to enlarge")
5,10-Dihydro-2-methyl-4H-thieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Impurity)
CAS: 221176-49-4
Ref. TR-D449185
| 5mg | 188.00 € | ||
| 10mg | 262.00 € | ||
| 25mg | 641.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Product Information
Name:
5,10-Dihydro-2-methyl-4H-thieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Impurity)
Synonyms:
- Olanzapine Imp. B (EP)
- Olanzapine USP Related Compound B
- Olanzapine USP RC B
- 2-Methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepin-4-one
- Olanzapine Lactame
- Olanzapine Related Compound B
- Olanzapine Impurity B
- Olanzapine EP IMpurity B
Description:
Impurity Olanzapine EP Impurity B/ Olanzapeine USP Related Compound B
Applications Olanzapine impurity (Olanzapine EP Impurity B).
References Fenselau, C., et al.: Xenobiotica, 22, 1207 (1992), Moore, N., et al.: J. Pharmacol. Exper. Ther., 262, 545 (1992), Kassahun, K., et al.: Drug Metab. Dispos., 25, 81 (1997),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
230.29
Formula:
C12H10N2OS
Color/Form:
Neat
InChI:
InChI=1S/C11H9Cl4NO2/c12-5-8(16-11(18)10(14)15)9(17)6-1-3-7(13)4-2-6/h1-4,8,10H,5H2,(H,16,18)
InChI key:
InChIKey=LVTDAJJOMLNXFS-UHFFFAOYSA-N
SMILES:
Cc1cc2c(s1)Nc1ccccc1NC2=O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-D449185 5,10-Dihydro-2-methyl-4H-thieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Impurity)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
